EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Gut Microbiome and Colistin Resistance: A Hidden Driver of Antimicrobial Failure

Ionela-Larisa Miftode iD, Andrei Vâţă iD, Radu-Ştefan Miftode iD, Alexandru Florinel Oancea iD, Maria-Antoanela Pasăre iD, Tudoriţa Gabriela Parângă iD, Egidia Gabriela Miftode iD, Irina Luanda Mititiuc, Viorel Dragoş Radu iD

International Journal of Molecular Sciences · 12.09.2025 · 26 (18) · 8899

DOI: 10.3390/ijms26188899 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.09.2025. Verfasst von Ionela-Larisa Miftode und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II (Infectious Diseases), Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Ro…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colistin, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colistin, a polymyxin antibiotic reintroduced as a last-resort therapy against multidrug-resistant Gram-negative bacteria, is increasingly being compromised by the emergence of plasmid-mediated colistin resistance genes (mcr-1 to mcr-10). The human gut microbiota serves as a major reservoir and transmission hub for these resistance determinants, even among individuals without prior colistin exposure. This review explores the mechanisms, dissemination, and clinical implications of mcr-mediated colistin resistance within the gut microbiota, highlighting its role in horizontal gene transfer, colonization, and environmental persistence. A comprehensive synthesis of the recent literature was conducted, focusing on epidemiological studies, molecular mechanisms, neonatal implications and decolonization strategies. The intestinal tract supports the enrichment and exchange of mcr genes among commensal and pathogenic bacteria, especially under antibiotic pressure. Colistin use in agriculture has amplified gut colonization with resistant strains in both animals and humans. Surveillance gaps remain, particularly in neonatal populations, where colonization may occur early and persist silently. Promising interventions, such as fecal microbiota transplantation and phage therapies, are under investigation but lack large-scale clinical validation. The gut microbiome plays a central role in the global spread of colistin resistance. Mitigating this threat requires integrated One Health responses, improved diagnostics for gut colonization, and investment in microbiome-based therapies. A proactive, multisectoral approach is essential to safeguard colistin efficacy and address the expanding threat of mcr-mediated resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColistinAnti-Bacterial AgentsDrug Resistance, BacterialHumansAnimalsGene Transfer, Horizontal

Stichwörter der Autor:innen

antimicrobial resistance (AMR)colistin resistancegut microbiotahorizontal gene transfer (HGT)mcr genesneonatal colonizationplasmid-mediated resistance

Substanzen

ColistinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Internal Medicine II (Infectious Diseases), Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.
  • "St Parascheva" Clinical Hospital of Infectious Diseases, 700116 Iasi, Romania.
  • Department of Internal Medicine I, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.
  • "St Spiridon" Emergency Hospital, 700115 Iasi, Romania.
  • Department of Urology, Faculty of Medicine, University of Medicine and Pharmacy "Gr. T. Popa", 700115 Iasi, Romania.
  • Department of Urology and Renal Transplantation, "C.I. Parhon" University Hospital, 700115 Iasi, Romania.

ORCID-Profile: Ionela-Larisa Miftode, Andrei Vâţă, Radu-Ştefan Miftode, Alexandru Florinel Oancea, Maria-Antoanela Pasăre, Tudoriţa Gabriela Parângă, Egidia Gabriela Miftode, Viorel Dragoş Radu

Zitieren

APA

Miftode, I. L., Vâţă, A., Miftode, R. Ş., Oancea, A. F., Pasăre, M. A., Parângă, T. G., Miftode, E. G., Mititiuc, I. L., & Radu, V. D. (2025). The Gut Microbiome and Colistin Resistance: A Hidden Driver of Antimicrobial Failure. International Journal of Molecular Sciences, 26(18), 8899. https://doi.org/10.3390/ijms26188899

Vancouver

Miftode IL, Vâţă A, Miftode RŞ, Oancea AF, Pasăre MA, Parângă TG, et al. The Gut Microbiome and Colistin Resistance: A Hidden Driver of Antimicrobial Failure. International Journal of Molecular Sciences. 2025;26(18):8899. doi:10.3390/ijms26188899

BibTeX
@article{Miftode2025,
  author = {Miftode, Ionela-Larisa and Vâţă, Andrei and Miftode, Radu-Ştefan and Oancea, Alexandru Florinel and Pasăre, Maria-Antoanela and Parângă, Tudoriţa Gabriela and Miftode, Egidia Gabriela and Mititiuc, Irina Luanda and Radu, Viorel Dragoş},
  title = {The Gut Microbiome and Colistin Resistance: A Hidden Driver of Antimicrobial Failure},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {18},
  pages = {8899},
  doi = {10.3390/ijms26188899}
}
Kostenlos starten →